{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-24-000187","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2024-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.405374+00:00","generated_at":"2026-05-30T11:23:43.433635+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Quest Diagnostics Q3 revenue +8.5% to $2.49B, raises FY revenue guidance","bullets":["Q3 revenue $2.49B (+8.5% YoY); reported EPS $1.99 (+1.5%); adjusted EPS $2.30 (+3.6%).","Organic revenue growth 4.2%; revenue per requisition +3.3%, volume +5.5%.","FY2024 revenue guidance raised to $9.80-9.85B (from $9.50-9.58B); adjusted EPS guidance unchanged at $8.85-8.95.","Hurricane Milton expected to reduce Q4 revenue by ~$15M and EPS by ~$0.08.","CEO cites customer wins and acquisitions including LifeLabs; 8 acquisitions targeted by year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-24-000187","json":"https://secwatch.observer/filing/0001022079-24-000187.json","markdown":"https://secwatch.observer/filing/0001022079-24-000187.md","text":"https://secwatch.observer/filing/0001022079-24-000187.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000187/0001022079-24-000187-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000187/dgx-20241022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:23:43.433635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}